MedTrace Logo

Plasma Rich in Growth Factors in Post-extraction Sockets

NCT03943680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-12

No results posted yet for this study

Summary

The purpose of this study is to compare the clinical success, radiographical volume maintenance and histological bone regeneration after using either a bovine bone xenograft or an autogenous platelet rich plasma enrich in growth factors, known as Endoret®-PRGF®.

Conditions

  • Tooth Extraction
  • Dental Implants

Interventions

DEVICE

PRGF

After tooth extraction, the socket will be grafted with PRGF-Endoret

DEVICE

ABB

After tooth extraction, the socket will be grafted with Geistlich Bio-Oss® Collagen

Sponsors & Collaborators

  • BTI Biotechnology Institute

    collaborator UNKNOWN

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Pablo Galindo-Moreno, DDS, PhD · Universidad de Granada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-04
Primary Completion
2024-11-18
Completion
2025-10-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03943680 on ClinicalTrials.gov